Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization.

Cells · 2019 · PMC6678194 · PMID 31323891

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The enrichment analysis revealed a highly significant positive correlation with the regulation of signal transduction (GO-term) and EGFR TKI resistance, different solid cancer types, namely pancreatic, prostate, and NSCLC as well as ErbB and HIF-1 signaling (KEGG pathway, Supplemental Tables S6 and S7 ). 4.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.